Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ViiV Healthcare
Marketing
GSK touts study showing tolerability edge for its long-acting PrEP
GSK's study evaluated the tolerability and acceptability of its long-acting PrEP drug Apretude compared with Gilead's rival Yeztugo.
Zoey Becker
Oct 15, 2025 8:45am
GSK allows generic versions of cabotegravir for HIV treatment
Jul 15, 2025 2:16pm
ViiV tops US patient groups' pharma reputation ranking
May 19, 2025 2:58pm
Pharma industry reputation slips again in patient group survey
Apr 29, 2025 2:00am
GSK’s ViiV plots next steps to fight HIV in Black communities
Feb 7, 2025 1:58pm
ViiV video series encourages deeper talks about life with HIV
Dec 6, 2024 4:10pm
